CRIO, a Boston-based technology firm streamlining clinical trials for sponsors, sites and patients, announced it has closed a $9M in Series B financing.

Innovation is at the heart of everything we do.  Our mission is to streamline clinical research to bring new medications to market faster. We have created a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines.  Today, CRIO supports more than 1000 medical research sites worldwide.
For more information about CRIO, visit www.clinicalresearch.io

http://crio-restaurant.com/

Other

Crio Secures $9M Series B Financing

Description

Company Information

Crio Secures $9M Series B Financing

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information